Mustang Bio Inc (MBIO)
0.2283
-0.01
(-3.14%)
USD |
NASDAQ |
Nov 15, 16:00
0.212
-0.02
(-7.14%)
After-Hours: 20:00
Mustang Bio Max Drawdown (5Y): 99.83% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 99.83% |
| September 30, 2024 | 99.83% |
| August 31, 2024 | 99.83% |
| July 31, 2024 | 99.83% |
| June 30, 2024 | 99.83% |
| May 31, 2024 | 99.76% |
| April 30, 2024 | 99.69% |
| March 31, 2024 | 98.80% |
| February 29, 2024 | 98.72% |
| January 31, 2024 | 98.72% |
| December 31, 2023 | 98.72% |
| November 30, 2023 | 98.50% |
| October 31, 2023 | 98.50% |
| September 30, 2023 | 97.87% |
| August 31, 2023 | 97.62% |
| July 31, 2023 | 97.62% |
| June 30, 2023 | 97.62% |
| May 31, 2023 | 97.62% |
| April 30, 2023 | 97.62% |
| March 31, 2023 | 97.37% |
| February 28, 2023 | 97.37% |
| January 31, 2023 | 97.37% |
| December 31, 2022 | 97.37% |
| November 30, 2022 | 96.65% |
| October 31, 2022 | 96.57% |
| Date | Value |
|---|---|
| September 30, 2022 | 96.57% |
| August 31, 2022 | 95.60% |
| July 31, 2022 | 95.60% |
| June 30, 2022 | 95.60% |
| May 31, 2022 | 95.15% |
| April 30, 2022 | 94.43% |
| March 31, 2022 | 94.43% |
| February 28, 2022 | 93.86% |
| January 31, 2022 | 91.83% |
| December 31, 2021 | 87.33% |
| November 30, 2021 | 85.42% |
| October 31, 2021 | 85.42% |
| September 30, 2021 | 85.42% |
| August 31, 2021 | 85.42% |
| July 31, 2021 | 85.42% |
| June 30, 2021 | 85.42% |
| May 31, 2021 | 85.42% |
| April 30, 2021 | 85.42% |
| March 31, 2021 | 85.42% |
| February 28, 2021 | 85.42% |
| January 31, 2021 | 85.42% |
| December 31, 2020 | 85.42% |
| November 30, 2020 | 85.42% |
| October 31, 2020 | 85.42% |
| September 30, 2020 | 85.42% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
82.44%
Minimum
Nov 2019
99.83%
Maximum
Jun 2024
92.05%
Average
94.79%
Median
Max Drawdown (5Y) Benchmarks
| Fortress Biotech Inc | 98.41% |
| AIM ImmunoTech Inc | 99.61% |
| Perspective Therapeutics Inc | 91.70% |
| Protalix BioTherapeutics Inc | 94.35% |
| Armata Pharmaceuticals Inc | 99.87% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -90.10 |
| Beta (5Y) | 1.926 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 117.8% |
| Historical Sharpe Ratio (5Y) | -0.5537 |
| Historical Sortino (5Y) | -1.314 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.62% |